The Current Status of Engineering Myocardial Tissue

Stem Cell Reviews and Reports

Volumn 7, Issue 1, 2011, Pages 172-180

  Sui, Runqian ^a   Liao, Xiaobo ^a   Zhou, Xinmin ^a   Tan, Qi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Myocardial infarction; Stem cells; Tissue engineering

Indexed keywords

EID: 78751642508     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9131-8     Document Type: Review

References (88)

1. Soonpaa, M. H., & Field, L. J. (1998). Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circulation Research, 83, 15-26.
2. Mann, D. L. (1999). Mechanisms and models in heart failure: a combinatorial approach. Circulation, 100, 999-1008.
3. Uemura, R., Xu, M., Ahmad, N., & Ashraf, M. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research, 98(11), 1414-21.
4. Griffith, L. G., & Naughton, G. (2002). Tissue engineering-current challenges and expanding opportunities. Science, 295(5557), 1009-14.
5. Taylor, D. A., Atkins, B. Z., Hungspreugs, P., Jones, T. R., Reedy, M. C., Hutcheson, K. A., et al. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Medicine, 4(8), 929-933.
6. Perez-Ilzarbe, M., Agbulut, O., Pelacho, B., Ciorba, C., San Jose-Eneriz, E., Desnos, M., et al. (2008). Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. European Journal of Heart Failure, 10(11), 1065-1072.
7. Hagège, A. A., Marolleau, J. P., Vilquin, J. T., Alhéritière, A., Peyrard, S., Duboc, D., et al. (2006). Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation, 114(1 Suppl), I108-13.
8. Hattan, N., Kawaguchi, H., Ando, K., Kuwabara, E., Fujita, J., Murata, M., et al. (2005). Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovascular Research, 65(2), 334-44.
9. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701-705.
10. Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., et al. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proceedings of the National Academy of Sciences USA, 98(18), 10344-9.
11. Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England Journal of Medicine, 355(12), 1210-1221.
12. Assmus, B., Honold, J., Schächinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. New England Journal of Medicine, 355(12), 1222-32.
13. Kawamoto, A., Gwon, H. C., Iwaguro, H., Yamaguchi, J. I., Uchida, S., Masuda, H., et al. (2001). Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation, 103(5), 634-7.
14. Kawamoto, A., Tkebuchava, T., Yamaguchi, J., Nishimura, H., Yoon, Y. S., Milliken, C., et al. (2003). Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation, 107(3), 461-8.
15. Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., et al. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circulation Research, 95, 911-921.
16. Rota, M., Padin-Iruegas, M. E., Misao, Y., De Angelis, A., Maestroni, S., Ferreira-Martins, J., et al. (2008). Local activation or implantation of cardiac progenitor cells rescues scarred infracted myocardium improving cardiac function. Circulation Research, 103, 107-16.
17. Padin-Iruegas, M. E., Misao, Y., Davis, M. E., Segers, V. F., Esposito, G., Tokunou, T., et al. (2009). Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation, 120(10), 876-87.
18. van Vliet, P., Roccio, M., Smits, A. M., van Oorschot, A. A., Metz, C. H., van Veen, T. A., et al. (2008). Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Netherlands Heart Journal, 16, 163-169.
19. Behfar, A., Zingman, L. V., Hodgson, D. M., Rauzier, J. M., Kane, G. C., Terzic, A., et al. (2002). Stem cell differentiation requires a paracrine pathway in the heart. FASEB Journal, 16, 1558-1566.
20. Klug, M. G., Soonpaa, M. H., Koh, G. Y., & Field, L. J. (1996). Genetically selected cardiomyocytes from differentiating embryonic stem cells from stable intracardiac grafts. Journal of Clinical Investigation, 98(1), 216-224.
21. Kehat, I., Khimovich, L., Caspi, O., Gepstein, A., Shofti, R., Arbel, G., et al. (2004). Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nature Biotechnology, 22, 1282-1289.
22. Laflamme, M. A., Gold, J., Xu, C., Hassanipour, M., Rosler, E., Police, S., et al. (2005). Formation of human myocardium in the rat heart from human embryonic stem cells. American Journal of Pathology, 167(3), 663-671.
23. Narazaki, G., Uosaki, H., Teranishi, M., Okita, K., Kim, B., Matsuoka, S., et al. (2008). Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation, 118(5), 498-506.
24. Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L. S., et al. (2008). Circulation, 118(5), 507-17.
25. Smits, P. C., van Geuns, R. J., Poldermans, D., Bountioukos, M., Onderwater, E. E., Lee, C. H., et al. (2003). Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. Journal of the American College of Cardiology, 42, 2063-2069.
26. Siminiak, T., Kalawski, R., Fiszer, D., Jerzykowska, O., Rzeźniczak, J., Rozwadowska, N., et al. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. American Heart Journal, 148(3), 531-7.
27. Abraham, M. R., Henrikson, C. A., Tung, L., Chang, M. G., Aon, M., Xue, T., et al. (2005). Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circulation Research, 97(2), 159-167.
28. Krause, D. S., Theise, N. D., Collector, M. I., Henegariu, O., Hwang, S., Gardner, R., et al. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell, 105, 369-377.
29. Yu, Y., Li, K., Bao, C., Liu, T., Jin, Y., Ren, H., et al. (2009). Ex vitro expansion of human placenta-derived mesenchymal stem cells in stirred bioreactor. Applied Biochemistry and Biotechnology, 159(1), 110-8.
30. Weissman, I. L. (2000). Stem cells: units of development, units of regeneration, and units in evolution. Cell, 100, 157-68.
31. Ferrari, G., Angelis, G. C., Colleta, M., Paolucci, E., Stornaiolo, A., Cossu, G., et al. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science, 279, 1528-1530.
32. Kohyama, J., Abe, H., Shimazaki, T., Koizumi, A., Nakashima, K., Gojo, S., et al. (2001). Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation, 68, 235-244.
33. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New England Journal of Medicine, 355(12), 1199-1209.
34. Meyer, G. P., Wollert, K. C., Lotz, J., Pirr, J., Rager, U., Lippolt, P., et al. (2009). Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. European Heart Journal, 30(24), 2978-84.
35. Young, P. P., Vaughan, D. E., & Hatzopoulos, A. K. (2007). Biologic properties of endothelial progenitor cells and their potential for cell therapy. Progress in Cardiovascular Diseases, 49(6), 421-429.
36. Narmoneva, D. A., Vukmirovic, R., Davis, M. E., Kamm, R. D., & Lee, R. T. (2004). Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation, 110(8), 962-968.
37. Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763-76.
38. Gonzalez, A., Rota, M., Nurzynska, D., Misao, Y., Tillmanns, J., Ojaimi, C., et al. (2008). Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circulation Research, 102(5), 597-606.
39. Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154-156.
40. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145-1147.
41. Chen, H., Hattori, F., Murata, M., Li, W., Yuasa, S., Onizuka, T., et al. (2008). Common marmoset embryonic stem cell can differentiate into cardiomyocytes. Biochemical and Biophysical Research Communications, 369(3), 801-6.
42. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-76.
43. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-20.
44. Park, I. H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., et al. (2008). Disease-specific induced pluripotent stem cells. Cell, 134, 877-86.
45. Park, I. H., Lerou, P. H., Zhao, R., Huo, H., & Daley, G. Q. (2008). Generation of human-induced pluripotent stem cells. Nature Protocols, 3, 1180-6.
46. Takahashi, M., Li, T. S., Suzuki, R., et al. (2006). Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. American Journal of Physiology - Heart and Circulatory Physiology, 291, 886-893.
47. Walter, D. H., & Dimmeler, S. (2002). Endothelial progenitor cells: regulation and contribution to adult neovascularization. Herz, 27, 579-588.
48. Frantz, S., Vallabhapurapu, D., Tillmanns, J., Brousos, N., Wagner, H., Henig, K., et al. (2008). Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction. European Journal of Heart Failure, 10, 119-24.
49. Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., et al. (2004). Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Medicine, 10, 494-501.
50. Rentrop, P., Blanke, H., Karsch, K. R., Kaiser, H., Köstering, H., & Leitz, K. (1981). Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation, 63(2), 307-17.
51. Menasché, P., Hagège, A. A., Vilquin, J. T., Desnos, M., Abergel, E., Pouzet, B., et al. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. Journal of the American College of Cardiology, 41(7), 1078-83.
52. Rafii, S., & Lyden, D. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nature Medicine, 9, 702-712.
53. Eschenhagen, T., & Zimmermann, W. H. (2005). Engineering myocardial tissue. Circulation Research, 97(12), 1220-31.
54. Akhyari, P., Fedak, P. W., Weisel, R. D., Lee, T. Y., Verma, S., Mickle, D. A., et al. (2002). Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation, 106(12 Suppl 1), I137-42.
55. Li, R. K., Jia, Z. Q., Weisel, R. D., Mickle, D. A., Choi, A., & Yau, T. M. (1999). Survival and function of bioengineered cardiac grafts. Circulation, 100, II63-II9.
56. Eschenhagen, T., Didié, M., Heubach, J., Ravens, U., & Zimmermann, W. H. (2002). Cardiac tissue engineering. Transplant Immunology, 9(2-4), 315-21.
57. Shao, Z. Q., Takaji, K., Katayama, Y., Kunitomo, R., Sakaguchi, H., Lai, Z. F., et al. (2006). Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model. Circulation Journal, 70(4), 471-7.
58. Kofidis, T., Lebl, D. R., Martinez, E. C., Hoyt, G., Tanaka, M., & Robbins, R. C. (2005). Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation, 112(9 Suppl), I173-7.
59. Kofidis, T., Akhyari, P., Boublik, J., Theodorou, P., Martin, U., Ruhparwar, A., et al. (2002). In vitro engineering of heart muscle: artificial myocardial tissue. Journal of Thoracic and Cardiovascular Surgery, 124(1), 63-9.
60. Leor, J., Aboulafia-Etzion, S., Dar, A., Shapiro, L., Barbash, I. M., Battler, A., et al. (2000). Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation, 102, III56-III61.
61. Christman, K. L., Fok, H. H., Sievers, R. E., Fang, Q., & Lee, R. J. (2004). Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Engineering, 10(3-4), 403-9.
62. Eschenhagen, T., Fink, C., Remmers, U., Scholz, H., Wattchow, J., Weil, J., et al. (1997). Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J, 11, 683-94.
63. Eschenhagen, T., Didie, M., Munzel, F., Schubert, P., Schneiderbanger, K., & Zimmermann, W. H. (2002). 3D engineered heart tissue for replacement therapy. Basic Research in Cardiology, 97(Suppl 1), I146-I152.
64. Ke, Q., Yang, Y., Rana, J. S., Chen, Y., Morgan, J. P., & Xiao, Y. F. (2005). Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice. Acta Physiologica Sinica, 57(6), 673-681.
65. Bursac, N., Papadaki, M., Cohen, R. J., Schoen, F. J., Eisenberg, S. R., Carrier, R., et al. (1999). Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. American Journal of Physiology, 277(2 Pt 2), H433-44.
66. Engelmayr, G. C., Jr., Cheng, M., Bettinger, C. J., Borenstein, J. T., Langer, R., & Freed, L. E. (2008). Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nature Materials, 7(12), 1003-10.
67. Piao, H., Kwon, J. S., Piao, S., Sohn, J. H., Lee, Y. S., Bae, J. W., et al. (2007). Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials, 28(4), 641-9.
68. Shimizu, T., Yamato, M., Isoi, Y., Akutsu, T., Setomaru, T., Abe, K., et al. (2002). Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circulation Research, 90(3), e40.
69. Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12(4), 459-65.
70. McDevitt, T. C., Woodhouse, K. A., Hauschka, S. D., Murry, C. E., & Stayton, P. S. (2003). Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. Journal of Biomedical Materials Research Part A, 66(3), 586-95.
71. Wang, Y., Liu, X. C., Zhao, J., Kong, X. R., Shi, R. F., Zhao, X. B., et al. (2009). Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization. Texas Heart Institute Journal, 36(2), 89-97.
72. Boerboom, R. A., Rubbens, M. P., Driessen, N. J., Bouten, C. V., & Baaijens, F. P. (2008). Effect of strain magnitude on the tissue properties of engineered cardiovascular constructs. Annals of Biomedical Engineering, 36(2), 244-53.
73. Mainil-Varlet, P., Rahn, B., & Gogolewski, S. (1997). Long-term in vivo degradation and bone reaction to various polylactides. 1. One year results. Biomaterials, 18(3), 257-66.
74. Christman, K. L., Vardanian, A. J., Fang, Q., Sievers, R. E., Fok, H. H., & Lee, R. J. (2004). Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. Journal of the American College of Cardiology, 44(3), 654-660.
75. Davis, M. E., Hsieh, P. C., Takahashi, T., Song, Q., Zhang, S., Kamm, R. D., et al. (2006). Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proceedings of the National Academy of Sciences USA, 103(21), 8155-8160.
76. Chaudhry, P. A., Mishima, T., Sharov, V. G., Hawkins, J., Alferness, C., Paone, G., et al. (2000). Passive epicardial containment prevents ventricular remodeling in heart failure. Annals of Thoracic Surgery, 70(4), 1275-80.
77. Saavedra, W. F., Tunin, R. S., Paolocci, N., Mishima, T., Suzuki, G., Emala, C. W., et al. (2002). Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. Journal of the American College of Cardiology, 39(12), 2069-76.
78. Kofidis, T., de Bruin, J. L., Hoyt, G., Ho, Y., Tanaka, M., Yamane, T., et al. (2005). Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. Journal of Heart and Lung Transplantation, 24(6), 737-744.
79. Zimmermann, W. H., Melnychenko, I., Wasmeier, G., Didié, M., Naito, H., Nixdorff, U., et al. (2006). Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Medicine, 12(4), 452-458.
80. Ott, H. C., Matthiesen, T. S., Goh, S. K., Black, L. D., Kren, S. M., Netoff, T. I., et al. (2008). Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nature Medicine, 14(2), 213-221.
81. Radisic, M., Deen, W., Langer, R., & Vunjak-Novakovic, G. (2005). Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. American Journal of Physiology - Heart and Circulatory, 288, H1278-89.
82. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. New England Journal of Medicine, 285, 1182-1186.
83. Rakusan, K., Flanagan, M. F., Geva, T., Southern, J., & van Praagh, R. (1992). Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation, 86, 38-46.
84. Kanamori, T., Watanabe, G., Yasuda, T., Nagamine, H., Kamiya, H., & Koshida, Y. (2006). Hybrid surgical angiogenesis: Omentopexy can enhance myocardial angiogenesis induced by cell therapy. Annals of Thoracic Surgery, 81, 160-7.
85. Suzuki, R., Hattori, F., Itabashi, Y., Yoshioka, M., Yuasa, S., Manabe-Kawaguchi, H., et al. (2009). Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochemical and Biophysical Research Communications, 387(2), 353-9.
86. Taheri, S. A., Ashraf, H., Merhige, M., Miletich, R. S., Satchidanand, S., Malik, C., et al. (2005). Myoangiogenesis after cell patch cardiomyoplasty and omentopexy in a patient with ischemic cardiomyopathy. Texas Heart Institute Journal, 32, 598-601.
87. Shao, Z. Q., Kawasuji, M., Takaji, K., Katayama, Y., & Matsukawa, M. (2008). Therapeutic angiogenesis with autologous hepatic tissue implantation and omental wrapping. Circulation Journal, 72(11), 1894-9.
88. Kuwabara, Y., Sato, A., Mitani, M., Shinoda, N., Hattori, K., Suzuki, T., et al. (2001). Use of omentum for medisastinal tracheostomy after total laryngoesophagectomy. Annals of Thoracic Surgery, 71, 409-413.